MAPK1 and Hyperglycemia: We found that the activity of the ERK/MAPK pathway was inhibited by euglycemia-CoCl2, hyperglycemia, and hyperglycemia combined with CoCl2 at 12 h which is measured by MAPK activation dual detection assay.